15 May 2025

23rd Congress of the Spanish Society of Neurosurgery: open day to the public

Zaragoza will host the Congress of the Spanish Society of Neurosurgery (SENEC), which will offer a public event for the first time on May 27th. Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, will explore cutting-edge topics such as epigenetics and its applications in brain surgery, among others.
14 May 2025

Neither responsible nor sustainable: Conference 'Gambling, a public health problem'

Last Friday, Zaragoza hosted a conference analyzing the effects of gambling on mental health. National leaders called for stronger public intervention through regulatory policies, effective prevention strategies, and appropriate care services. The GAMBL-OUT and GAMBL-HID projects, led by researchers from the IIS Aragón, were also presented.
13 May 2025

The Mediterranean diet from an early age could help prevent excess weight in childhood.

The study, led by the IIS Aragón and the University of Zaragoza, analyzed more than 1.200 children between the ages of 3 and 6 in seven Spanish cities. Children with a higher adherence to the Mediterranean diet had a lower BMI and less total and abdominal fat, especially in the case of girls.
12 May 2025

The Ministry of Health announces the 1st HumanizAR and CuidAR Awards for Aragon

The call is sponsored by the General Directorate of Care and Humanization and the IIS Aragón, with the collaboration of Roche. The deadline for submitting applications is June 24, and professionals from all eight healthcare sectors in Aragón are eligible to participate.
8 May 2025

Aspanoa invests 120.000 euros to promote new immunotherapies for childhood cancer.

It will be distributed equally between two research projects. One is led by Diego Sánchez (IIS Aragón) and the other by Eva Gálvez (CSIC) and Ramón Hurtado (BIFI – Unizar). Immunotherapy is a treatment already being applied to some cancer patients, including children, when standard therapies are insufficient.
7 May 2025

The Zaragoza III Health Sector, recognized as a Center Committed to Excellence in Care

The designation ceremony, held on May 6 at the Lozano Blesa University Clinical Hospital, commemorated this international recognition with more than XNUMX attendees, three roundtable discussions with professionals and patients, and the presentation of official diplomas.
6 May 2025

A new experimental drug improves motor function and prolongs life in an ALS model.

The MP-010 molecule, developed by Miramoon Pharma, acts on ryanodine receptors, opening a new therapeutic avenue for treating ALS, according to a study led by researchers from CIBERNED and several research institutes, including the IIS Aragón.
2 May 2025

Conference 'Gambling, a Public Health Problem', May 9

The CaixaForum Zaragoza Auditorium will host a conference addressing gambling as a public health issue. The event will also present two innovative prevention projects, GAMBL-OUT and GAMBL-HID, led by researchers from the IIS Aragón.